The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Page 331
Kendrick P. 1942. Use of alum-treated
pertussis vaccine, and of alum-precipitated combined pertussis
vaccine and diphtheria toxoid, for active immunization. American
Journal of Public Health 32:615-626.
Kendrick P. 1943. A field study of
alum-precipitated combined pertussis vaccine and diphtheria toxoid
for active immunization. American Journal of Hygiene
38:193-202.
Kendrick P, Eldering G. 1936. Progress
report on pertussis immunization. American Journal of Public Health
26:8-12.
Kendrick P, Eldering G. 1939. A study in
active immunization against pertussis. American Journal of Hygiene
29:133-153.
Kilroy AW, Schaffner W, Fleet WF,
Lefkowitz LB, Karzon DT, Fenichel GM. 1970. Two syndromes following
rubella immunization: clinical observations and epidemiological
studies. Journal of the American Medical Association
214:2287-2292.
Koplan JP, Hinman AH. 1987. Decision
analysis, public policy, and pertussis: are they compatible?
Medical Decision Making 7:72-73.
Kulenkampff M, Schwartzman JS, Wilson J.
1974. Neurological complications of pertussis inoculation. Archives
of Disease in Childhood 49:46-49.
Lerman SJ, Nankervis GA, Heggie AJ, Gold
E. 1971. Immunologic response, virus excretion and joint reactions
with rubella vaccine: a study of adolescent girls and young women
given live attenuated virus vaccine (HPV-77:DE-5). Annals of
Internal Medicine 74:67-73.
Madsen T. 1925. Whooping cough: its
bacteriology, diagnosis, prevention, and treatment. Boston Medical
and Surgical Journal 192:50-60.
Madsen T. 1933. Vaccination against
whooping cough. Journal of the American Medical Association
101:187-188.
Manclark CR, ed. 1990a. Sixth
International Symposium on Pertussis, Abstracts. DHHS Publication
No. (FDA) 90-1162. Bethesda, MD: Public Health Service, U.S.
Department of Health and Human Services.
Manclark CR, ed. 1990b. Proceedings of the
Sixth International Symposium on Pertussis. DHHS Publication No.
(FDA) 90-1164. Bethesda, MD: Public Health Service, U.S. Department
of Health and Human Services.
Marcuse EK, Wentz KR. 1990. The NCES
reconsidered: summary of a 1989 workshop. Vaccine 8:531-535.
Menkes JH, Kinsbourne M. 1990. Workshop on
neurologic complications of pertussis and pertussis vaccination.
Neuropediatrics 21:171-176.
Osler J. 1988. Judgment in Rothwell vs.
Raes, Hall, and Connaught Laboratories. Supreme Court of Ontario,
November 18, 1988. Toronto.
Plotkin SA. 1988. Rubella vaccine. In:
Plotkin SA, Mortimer EA, Jr., eds. Vaccines. Philadelphia: W.B.
Saunders Co.
Pollock TM, Morris J. 1983. A 7-year
survey of disorders attributed to vaccination in North West Thames
region. Lancet 1:753-757.
Rowlands DF, Freestone DS. 1971.
Vaccination against rubella of susceptible schoolgirls in Reading.
Journal of Hygiene 69:579-586.
Sauer L. 1933a. Whooping cough: a study in
immunization. Journal of the American Medical Association
101:239-241.
Sauer L. 1933b. Immunization with bacillus
pertussis vaccine. Journal of the American Medical Association
101:1449-1451.
Schaffner W, Fleet WF, Kilroy AW,
Lefkowitz LB, Herrmann KL, Thompson J, Karzon DT. 1974.
Polyneuropathy following rubella immunization: a follow-up study
and review of the problem. American Journal of Diseases of Children
127:684-688.
Spruance SL, Smith CB. 1971. Joint
complications associated with derivatives of HPV-77 rubella virus
vaccine. American Journal of Diseases of Children 122:105-111.